§Efficacy
demonstrated in 5 double-blind, randomized, placebo-controlled
trials
§Safe and well
tolerated
§Adverse
events are generally dose dependent and manageable by typical dose
titration
§No
evidence for an adverse effect of ranolazine
on survival